These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38041122)

  • 1. Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis.
    Ma N; Ming X; Chen J; Wu KL; Lu J; Jiang G; Mao J
    Radiat Oncol; 2023 Dec; 18(1):195. PubMed ID: 38041122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility.
    Sun J; Wang Z; Sheng Y; Ming X; Jiang GL; Wang W
    Strahlenther Onkol; 2022 Apr; 198(4):361-369. PubMed ID: 34618172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy: A propensity score-matched analysis.
    Li Y; Guan X; Xing X; Hu C
    Head Neck; 2024 Jul; 46(7):1766-1776. PubMed ID: 38591178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy.
    Chen J; Lu JJ; Ma N; Zhao J; Chen C; Fan M; Jiang G; Mao J
    Radiat Oncol; 2019 Jan; 14(1):16. PubMed ID: 30683133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study.
    Qiu X; Gao J; Yang J; Hu J; Hu W; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1193. PubMed ID: 36544659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world.
    Zhang W; Hu W; Hu J; Gao J; Yang J; Kong L; Lu JJ
    Cancer Sci; 2020 Dec; 111(12):4465-4479. PubMed ID: 32936975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
    Modesto A; Dalmasso C; Lusque A; Vieillevigne L; Izar F; Moyal E; Carrère N; Guimbaud R; Rives M
    Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
    Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of definitive carbon-ion radiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
    Isozaki T; Ishikawa H; Yamada S; Nabeya Y; Minashi K; Murakami K; Matsubara H
    Esophagus; 2024 Oct; 21(4):523-529. PubMed ID: 38814482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
    Lertbutsayanukul C; Kitpanit S; Kannarunimit D; Chakkabat C; Oonsiri S; Thephamongkhol K; Puataweepong P; Katanyoo K; Sukhaboon J; Tovanabut C; Chongsathientham S; Treeratsapanich P; Soonthornrak J; Prayongrat A
    Trials; 2022 Oct; 23(1):897. PubMed ID: 36273186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma.
    Hu J; Huang Q; Gao J; Hu W; Yang J; Guan X; Qiu X; Zhang W; Kong L; Lu JJ
    Front Oncol; 2021; 11():653050. PubMed ID: 34367954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.
    Roeder F; Nicolay NH; Nguyen T; Saleh-Ebrahimi L; Askoxylakis V; Bostel T; Zwicker F; Debus J; Timke C; Huber PE
    Radiat Oncol; 2014 Aug; 9():191. PubMed ID: 25175056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric Comparison Between Carbon-ion Radiotherapy and Photon Radiotherapy for Stage I Esophageal Cancer.
    Takakusagi Y; Yoshida D; Kusano Y; Kano K; Anno W; Tsuchida K; Mizoguchi N; Serizawa I; Katoh H; Imura K; Takayama Y; Minohara S; Kamada T
    In Vivo; 2021; 35(1):447-452. PubMed ID: 33402495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.